29.340
29.34 (0%)
As of Dec 20, 2024
Akero Therapeutics, Inc. [AKRO]
Source:
Company Overview
Akero Therapeutics, Inc is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including non-alcoholic steatohepatitis, or NASH, a disease without any approved therapies.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | 650-487-6488 |
Industry | manufacturing |
CEO | Andrew Cheng |
Website | www.akerotx.com |